Lymphoma Manufacturers, Suppliers & Companies (Clinical Medicine)
-
Manufacturerbased in Munich, GERMANY
ImevaX is a Biotech company based in Munich with a focus on facilitating H. pylori Diagnostics with a novel Rapid Diagnostic ...
-
Manufacturerbased in London, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
-
Technologybased in Cambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
-
Manufacturerbased in Notting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
Cartherics - Autologous T cells
This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer ...
CONTACT SUPPLIER -
Manufacturerbased in Sevilla, SPAIN
Vitro S.A. is a Spanish private corporation specialized in the development, manufacturing and distribution of In-Vitro diagnostic (IVD) instruments, software and reagents, which use non-invasive techniques like immunohistochemistry and molecular ...
-
Manufacturerbased in Santee, CALIFORNIA (USA)
SCANTIBODIES Laboratory…A Vision Fulfilled…the Challenge for Today! Over forty five years ago, a 25-year old man and his wife had a vision for helping people by integrating biochemistry into diagnostic products with a goal of stopping the ...
-
Technologybased in Seattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
Cancer Treatment Services
AVM0703 Induces & Mobilizes Gamma Delta+ NKT-Cells. AVM0703 triggers the production and release of gamma delta+ Natural Killer T-cells (AVM-NKT). These supercharged immune cells have unique properties and appear rapidly in the blood following a ...
CONTACT SUPPLIER -
Manufacturerbased in New York, NEW YORK (USA)
Aurora Biopharma is founded on a single mission to revolutionize the treatment of cancer, by using the human body’s immune system. Aurora is developing state-of-the-art cancer immunotherapy, a form of adoptive cell transfer called Chimeric Antigen ...
-
Manufacturerbased in Planegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor
Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you